NCT04102462View on ClinicalTrials.gov

A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

October 8, 2020

Study Completion Date

October 8, 2020

Conditions
Healthy
Interventions
DRUG

BI 764198

Capsules

DRUG

Matching placebo

Capsules

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04102462 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198 | Biotech Hunter | Biotech Hunter